The Latest Breaking News from the US Food and Drug Administration

For years, the drug phenylephrine has been a popular choice for relieving nasal congestion, however, the US Food and Drug Administration (FDA) is considering removing oral phenylephrine medicines from pharmacy shelves. Recent FDA findings suggest it lacks effectiveness.

The weight-loss jab Wegovy made its debut on June 4 2021. It was the first new weight-loss drug to be approved by the US Food and Drug Administration since 2014.

An Apple update has been welcomed by hearing experts

The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To capitalize on the industry’s expansion, it could be wise to invest in fundamentally sound biotech stocks, Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which have the potential to revolutionize medicine. Read…

As the global population ages, the demand for healthcare services surges, making the sector a promising avenue for long-term growth. Investors looking to capitalize on this trend might consider adding healthcare giants like Eli Lilly and Company (LLY), UnitedHealth Group (UNH), and Merck & Co. (MRK) to their watchlist. Read…

Old newspaper boxes are being repurposed into containers that distribute Narcan, an emergency treatment to reverse drug overdoses

Just a few days after Apple unveiled the Hearing Aid feature for AirPods Pro 2, the US Food and Drug Administration (FDA) authorized it, marking the first-ever 'Over-the-Counter Hearing Aid Software' to be approved.

Oral nicotine pouches – like Zyn and Velo in the U.S. – appear to be less toxic than cigarettes and deliver comparable levels of nicotine. This makes them an alternative for people who smoke. However, people who’ve never smoked are using them, too, and youth are open to trying them.…

The agency stressed the material is inactivated and that the findings "do not represent actual virus that may be a risk to consumers," but it's continuing to study the issue.

The US Food and Drug Administration has given the green light for a popular anti-obesity drug to be used to prevent serious heart conditions for the first time, in a move likely to expand insurance coverage.

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….